Results 161 to 170 of about 553,116 (313)

Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg. [PDF]

Front Cell Infect Microbiol
Wen C, He T, Zha G, Li A, Wang Z, Zhou Z, Cai D, Zhang D, Peng M, Shi X, Ren H.   +10 more
europepmc   +1 more source

Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens

Hepatology, 2006
M. Sugiyama, Yasuhito Tanaka, Takanobu Kato, E. Orito, Kiyoaki Ito, S. Acharya, R. Gish, A. Kramvis, T. Shimada, N. Izumi, M. Kaito, Y. Miyakawa, M. Mizokami   +12 more
semanticscholar   +1 more source

Hepatitis E virus and renal injury: A review of pathogenesis, pathology, and clinical management. [PDF]

Infect Med (Beijing)
Shen J, Zhang S.
europepmc   +1 more source

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Journal of Clinical Investigation, 1992
S. Tsai, P. Chen, M. Lai, P. M. Yang, J. Sung, J. Huang, L. Hwang, T. Chang, D. S. Chen   +8 more
semanticscholar   +1 more source

A Personalised Vaccination Program Based on Immune Reconstitution in Paediatric Cancer Survivors

Acta Paediatrica, EarlyView.
ABSTRACT Aims Paediatric cancer survivors often experience treatment‐induced immunosuppression, requiring post‐treatment revaccination. However, immune recovery timelines vary, and current revaccination guidelines, largely based on data of varied quality derived from studies on acute‐lymphoblastic‐leukaemia (ALL), may not be applicable across all ...
Menucha Jurkowicz, Raz Somech, Dan Dominissini, Nathan Keller, Efrat Dresner, Michal Paret, Gilad Sherman, Guy Katzenellenbogen, Elina Gelman, Keren Asraf, Ram Doolman, Atar Lev, Amos J. Simon, Helly Vernitsky, Assaf Barg, Hana Golan, Amos Toren, Michal Stein   +17 more
wiley   +1 more source

Semaphorin 3B-Membranous Nephropathy in Adults. [PDF]

Kidney Int Rep
Arevalo Salazar D, Theis JD, Perrizo RL, Mary FE, Sethi S.   +4 more
europepmc   +1 more source

Correlation of Bile Acid Dynamics to Bulevirtide Response and Disease Severity in Patients With Hepatitis D

Alimentary Pharmacology &Therapeutics, EarlyView.
Bulevirtide increases bile acid levels in most patients; however, changes in bile acids do not predict virological response or adverse events, nor do they reflect treatment adherence. After discontinuation of bulevirtide, bile acid levels rapidly decline.
Marlene Hintersteininger, Michael Schwarz, Philipp Schwabl, Lukas Hartl, Lorenz Balcar, Benedikt Silvester Hofer, Georg Kramer, Christian Sebesta, Paul Thöne, Patrik Attalla, Michael Gschwantler, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Mathias Jachs   +14 more
wiley   +1 more source

Bivalent virus-like particles expressing SPECT1 and CSP trigger pre-erythrocytic malaria immunity and protect against transgenic <i>Plasmodium falciparum</i> sporozoite challenge in mice. [PDF]

Front Immunol
Turan G, Mukhopadhyay E, Truby A, Fedorova K, Peralta Alvarez MP, Alharbi NK, Hill AVS, Salman AM.   +7 more
europepmc   +1 more source

Temporal Association Between COVID‐19 Vaccination and HBsAg Loss in Chronic Hepatitis B Infection: An Interrupted Time Series Analysis

Alimentary Pharmacology &Therapeutics, EarlyView.
In 59,946 chronic hepatitis B patients followed over 23 years, COVID‐19 vaccination rollout was temporally associated with a 56% increase in HBsAg loss rates (peak 1.27 per 100 person‐years in 2022), followed by gradual waning. Negative control outcomes showed no similar pattern, supporting biological specificity. ABSTRACT Background and Aims Hepatitis
Jonggi Choi, Allison Carroll, Vy H. Nguyen, Megan Michta, Xuan Q. Zhang, Young‐Suk Lim, Raymond T. Chung   +6 more
wiley   +1 more source

Dysfunction of circulating follicular helper T cells in people living with HIV who are HBV small surface protein antibody (HBsAb)-negative despite HBV vaccination. [PDF]

BMC Infect Dis
Sedohara A, Kanno Y, Arai K, Arizono K, Koga M, Nakahara F, Saito M, Adachi E, Yotsuyanagi H.   +8 more
europepmc   +1 more source